CoChat

Ba/F3 cells and their use in kinase drug discovery

Warmuth, Markus, Kim, Sungjoon, Gu, Xiang-ju, Xia, Gang, Adrián, Francisco · 2007 · Current Opinion in Oncology

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Abstract

Purpose of review Due to their ability to function as dominant oncogenes, protein kinases have become favored targets in the quest for 'molecularly-targeted' cancer chemotherapeutics. The discovery of a large number of cancer-associated mutations in the kinome, and the progress in developing specific small-molecule kinase inhibitors has increased the need for accurate, reproducible, and efficient kinase activity-dependent cellular assay systems. Recent findings Ba/F3, a murine interleukin-3 dependent pro-B cell line is increasingly popular as a model system for assessing both the potency and downstream signaling of kinase oncogenes, and the ability of small-molecule kinase inhibitors to block kinase activity. Facilitated by their growth properties, Ba/F3 cells have recently been adapted to high-throughput assay formats for compound profiling. Further, several published approaches show promise in predicting resistance to small-molecule kinase inhibitors elicited by point mutations interfering with inhibitor binding. Summary Ba/F3 cells are an increasingly popular tool in kinase drug discovery. The ability to test the transforming capacity of newly identified kinase mutations, and to profile drug candidates and compound libraries in high-throughput fashion, combined with the use of Ba/F3 cells to predict clinical resistance will greatly facilitate developments in this field.

Overview

Integrity signals

Registry

Crossref · 10.1097/cco.0b013e328011a25f

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 60 references

Cited by

See all 268

Metadata

Authors
Warmuth, M., Kim, S., Gu, X.-J., Xia, G., & Adrián, F.
Affiliations
Genomics Institute of the Novartis Research Foundation (US)
Corresponding author
Warmuth, Markus
Venue
Current Opinion in Oncology
Published
2007-01
Volume
19
Issue
1
Pages
55-60
ISSN
1040-8746 (ISSN-L)
OpenAlex
W2088757697
Cited by
240
References
60
Citations by year
2026: 7 · 2025: 14 · 2024: 27 · 2023: 22 · 2022: 25 · 2021: 19 · 2020: 18 · 2019: 5 · 2018: 13 · 2017: 14 · 2016: 14 · 2015: 9 · 2014: 11 · 2013: 10 · 2012: 7
FWCI
0.63
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Oncology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations
Keywords
Ba/F3 cells, protein kinases, kinase inhibitors, kinase drug discovery, oncogenes, small-molecule kinase inhibitors, high-throughput screening, compound profiling, drug resistance prediction, point mutations, downstream signaling, interleukin-3 dependence
MeSH terms
Animals, Antineoplastic Agents, Cell Line, Cell Transformation, Neoplastic, Epidermal Growth Factor, Drug Design, Signal Transduction, Drug Resistance, Neoplasm, Protein Kinase Inhibitors, Mice, ErbB Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ba/F3 cells and their use in kinase drug discovery. https://app.cochat.ai/papers/10.1097/cco.0b013e328011a25f
The paper
Warmuth, M., Kim, S., Gu, X.-J., Xia, G., & Adrián, F. (2007). Ba/F3 cells and their use in kinase drug discovery. Current Opinion in Oncology. https://doi.org/10.1097/cco.0b013e328011a25f

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.